Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re MSAR Licensing and Upstream Trial

18 Jun 2020 07:00

RNS Number : 3041Q
Quadrise Fuels International PLC
18 June 2020
 

18 June 2020

 

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Further Statement re MSAR® Licensing and Upstream Trial

 

Further to the Company's announcement of 17 June 2020 relating to the announcement made by TomCo Energy plc ("TomCo") that morning, Quadrise provides the following update pursuant to discussions between the Company and Valkor Technologies LLC ("Valkor") and concerning:

 

· a commercial trial of MSAR® technology at a test plant to process up to 500 barrels of heavy crude oil per day on the Petroteq Energy Inc's site in Utah, USA which is managed by Valkor ("Phase 1"); and

 

· the development of commercial MSAR® plants of up to 10,000 barrels oil per day ("Phase 2").

 

As announced on 17 June 2020, both the Company and Valkor continue to believe that the use of MSAR® technology can add significant value to the development of heavy and paraffinic oil deposits in Utah. Quadrise confirms that it has agreed in principle to the deployment of MSAR® trial equipment for Phase 1 at a price of up to US$150,000. Additionally, Quadrise will continue to work in good faith to finalise the process design and trial agreement for Phase 1 with Valkor, including the terms of the scope and timing of the trial.

 

In parallel with Phase 1, Quadrise and Valkor will continue to cooperate in good faith to agree the commercial terms of a conditional MSAR® licence and commercial supply agreement for the production of MSAR® fuel under Phase 2. QFI has agreed with Valkor that any licence ultimately granted to Valkor under the terms of the memorandum of understanding will be limited to the deployment of MSAR® technology in Utah, USA in connection with the processing of sweet heavy or paraffinic crude oil and will be capable of being assigned to Valkor group joint ventures in the future.

 

A conditional licence will only be finalised upon, and following, inter alia, satisfactory results of the Phase 1 testing, the agreement between the parties as to Phase 2 commercial terms and the entry of binding agreements.

 

Further announcements will be made, as appropriate, in due course.

 

Mike Kirk, Chairman, QFI said:

 

"We look forward to continuing our discussions with Valkor and to progressing the trial in Utah with Valkor and their partners, including TomCo, to demonstrate the effectiveness of our technology in enabling the sweet heavy or paraffinic oil deposits there, and the subsequent commercial development."

 

For further information, please refer to the Company's website at www.quadrisefuels.com, or contact ir@quadrisefuels.com or phone:

 

Quadrise Fuels International Plc

 

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

 

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

David McKeown 

 

 

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

Quadrise@fticonsulting.com

 

Notes to Editors

 

QFI is the supplier of MSAR® emulsion technology and fuels, a low-cost alternative to heavy fuel oil (one of the world's largest fuel markets, comprising over 450 million tons per annum) in the global power generation, shipping, industrial and refining industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRMZGMVGRGGGZG
Date   Source Headline
31st Oct 20167:00 amRNSResult of Open Offer
28th Oct 201611:53 amRNSHolding(s) in Company
26th Oct 20164:46 pmRNSHolding(s) in Company & Director/PDMR Shareholding
18th Oct 20167:00 amRNSNew Corporate Website
14th Oct 20167:00 amRNSOpen Offer
12th Oct 20162:46 pmRNSResults of Placing
12th Oct 20167:01 amRNSProposed Placing and Proposed Open Offer
12th Oct 20167:00 amRNSFinal Results
30th Sep 20167:00 amRNSOperational Update
14th Sep 20167:00 amRNSExtension of Contracts with AkzoNobel
11th Aug 20165:20 pmRNSHolding(s) in Company
10th Aug 20168:43 amRNSMemorandum of Understanding
21st Jul 20167:00 amRNSDirectorate Change
12th Jul 20164:24 pmRNSDirector/PDMR Shareholding
5th Jul 20162:05 pmRNSDirector/PDMR Shareholding
5th Jul 20167:00 amRNSEnd of Year Update
28th Jun 20163:09 pmRNSHolding(s) in Company
13th Jun 20164:40 pmRNSSecond Price Monitoring Extn
13th Jun 20164:35 pmRNSPrice Monitoring Extension
10th Jun 20164:40 pmRNSSecond Price Monitoring Extn
10th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Apr 20165:11 pmRNSIssue of Options and Director's Dealing
1st Apr 20167:00 amRNSFurther re Directorate Change
24th Mar 20164:13 pmRNSIssue of Options and Directors' Dealings
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 20163:04 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSHalf Yearly Report
17th Mar 20161:11 pmRNSMarine Programme Update
3rd Mar 20164:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:13 pmRNSNotice of Interim Results
2nd Feb 20167:00 amRNSDirectorate Change
21st Dec 20152:24 pmRNSDirector/PDMR Shareholding
17th Dec 20154:40 pmRNSSecond Price Monitoring Extn
17th Dec 20154:35 pmRNSPrice Monitoring Extension
14th Dec 20152:23 pmRNSFeasibility Study Contract
27th Nov 20154:16 pmRNSResult of AGM
23rd Nov 20157:00 amRNSDirectorate Change
19th Nov 20157:00 amRNSUpdate re Research & Development Programmes
4th Nov 20154:47 pmRNSPosting of Annual Report and Notice of AGM
2nd Nov 20154:35 pmRNSPrice Monitoring Extension
15th Oct 20154:40 pmRNSSecond Price Monitoring Extn
15th Oct 20154:35 pmRNSPrice Monitoring Extension
12th Oct 20157:00 amRNSFinal Results
1st Oct 20155:38 pmRNSHolding(s) in Company
16th Sep 20157:00 amRNSHalf Year Update on Major Active Programmes
25th Aug 20154:41 pmRNSSecond Price Monitoring Extn
25th Aug 20154:35 pmRNSPrice Monitoring Extension
13th Aug 20154:35 pmRNSPrice Monitoring Extension
12th Aug 20154:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.